American Heart Association International Stroke Conference OnDemand 2022

+ Include: 104 Videos (.mp4) + 104 Audios (.mp3) + 104 Subtitles (.vtt) + 104 PDFs, size: 68.31 GB

+ Target Audience: neurologists, neurosurgeons, and stroke care specialists

+ Information:

1. Overview

The American Heart Association International Stroke Conference OnDemand 2022 presents cutting-edge research, clinical trials, and advancements in cerebrovascular disease. The program explores a wide spectrum of stroke care, including neurointerventional techniques, acute medical management, rehabilitation, and preventive strategies to enhance stroke recovery and reduce the global burden of the disease.

Course Date: 2022

2. Learning Objectives

• Evaluate the latest late-breaking science and clinical trials shaping acute stroke management and cerebrovascular disease care.

• Implement advanced neuroendovascular techniques and medical therapies for acute ischemic and hemorrhagic strokes.

• Analyze the impact of health equity, social determinants, and sex differences on stroke risk and recovery.

• Integrate emerging technologies, artificial intelligence, and advanced imaging modalities into stroke diagnosis and treatment.

• Optimize post-stroke rehabilitation, transition of care protocols, and secondary stroke prevention strategies.

3. Target Audience

Best for neurologists, neurosurgeons, and stroke care specialists who want updates on neurointerventions, clinical trials, and rehabilitation.

4. Topics

1. Accelerating Access to Stroke Thrombectomy in Low And Middle-Income Countries

2. Acute Care

3. Acute Nonendovascular Treatment Oral Abstracts I

4. Advanced Practice Providers and Therapists Oral Abstracts I

5. An Update on Sex Differences in Stroke Risk Factors Management and Outcomes Moving Towards Personalized Stroke Prevention….

6. Andexxa Clinical Conversation Mechanism of Action

7. Aneurysms and Vascular Malformations Oral Abstracts I

8. Arts Therapies and Stroke Rehabilitation Humanities for the Sake of Science

9. ASA-Bugher Foundation Centers of Excellence in Hemorrhagic Stroke

10. Atrial Fibrillation after Large and Small Vessel Stroke Are You Missing the Forest for the Trees

11. Beyond Observations Interventions to Reduce Sex Differences in Stroke

12. Brain Health Oral Abstracts I

13. Care Across the Continuum

14. Career Trajectory after Stroke Fellowship Advancement and Obstacles

15. CED Talks (Cerebrovascular Education and Discovery)

16. Cerebral Edema_ From Monitoring to Management

17. Cerebral Venous Thrombosis

18. Cerebrovascular Manifestations of COVID-19 Oral Abstracts I

19. Cerebrovascular Nursing Oral Abstracts I

20. Cerebrovascular Systems of Care Oral Abstracts I

21. Cerebrovascular Systems of Care Oral Abstracts II

22. Clinical Considerations in Stroke or Transient Ischemic Attack

23. Clinical Quandaries in ICH

24. Clinical Rehabilitation and Recovery Oral Abstracts I

25. Closing Main Event

26. Cocktails anyone Intravenous Thrombolysis Symposium

27. Complexities and Complications_Case-based Conversations in Mechanical Thrombectomy

28. Early Clinical Multi-Center Experience with the BOBBY Balloon Guide Catheter_ A new generation of Balloon Guide Catheters

29. Effect of Marijuana on Brain Health

30. Emerging Therapeutics in SAH (Translational)

31. Evidence-Based Pragmatic Solutions and Policy Interventions for Reducing the Global Burden of Stroke

32. EVT for MeVO and Distal LVO_ No Clot Left Behind

33. Flow Diverters for Aneurysm Treatment_ What, When and How

34. FRED X Flow Diverter Early Clinical Experience in the U.S. & Europe

35. From the Heart to the Brain What You Need to Know about Cardiac Monitoring in Stroke Patients

36. Frontiers of Brain Imaging

37. Game of Strokes

38. Get Down with you Blood Pressure _ Dance Break @ISC22

39. HEADS-UP_ Health Equity and Actionable Disparities in Stroke_ Understanding and Problem-solving

40. Health Services, Quality Improvement, and Patient-Centered Outcomes Oral Abstracts I

41. Health Services, Quality Improvement, and Patient-Centered Outcomes Oral Abstracts II

42. Health Services, Quality Improvement, and Patient-Centered Outcomes Oral Abstracts III

43. ICH Explorations_ New Concepts and Outcome Implications

44. ICH Management_ Now and Into the Next Decade

45. Identifying Best Practices to Improve Evaluation and Management of In-hospital Inpatient Stroke_AHA Scientific Statement

46. Image Guided Diagnosis, Intervention and Mobile Stroke Units for Stroke

47. Imaging Oral Abstracts I

48. Imaging Oral Abstracts II

49. Imaging Oral Abstracts III

50. Incidental Lacunes on Brain Imaging_ How to Manage Them

51. In-Hospital Care; from the ICU to Discharge Oral Abstracts I

52. Interpreting Neurovascular Imaging for Stroke Providers

53. Intersection of Goals of Care in Cerebrovascular Disease_ Tracheostomy and Palliative Care

54. Intracerebral Hemorrhage Oral Abstracts I

55. ISC 2022 Showcase

56. Just a Little Fib_ Stroke Risk or White Lie_

57. Late-Breaking Science Oral Abstracts I

58. Late-Breaking Science Oral Abstracts II

59. Late-Breaking Science Oral Abstracts III

60. Leveraging NIH Stroke Scale Knowledge and Skills

61. Maximizing Your Reach, Publishing as an Early Career or Trainee (a Joint AHA_ASA and SVIN Session)

62. Mechanisms and Outcomes of Covid-Induced Cerebrovascular Injury

63. My Volunteer Journey with the AHA and its Impact on My Career

64. Neurocritical Care of Patients on Extra-Corporeal Membrane Oxygenation (ECMO)

65. Neuroendovascular Oral Abstracts I

66. Neuroendovascular Oral Abstracts II

67. Neuroendovascular Oral Abstracts III

68. NeuroInterventional Training for Neurologists (a Joint AHA_ASA and SVIN Session)

69. Neuroprotection in the EVT Era_ Better Start Paying Attention

70. Non-Acute Large Vessel Disease from Veins to Arteries Oral Abstracts I

71. Novel Approaches to Attack the Clot_ Beyond Tissue Plasminogen Activators

72. Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease

73. Opening Main Event

74. Pediatric Cerebrovascular Disease Oral Abstracts I

75. Pediatric Cerebrovascular Interventions_ The Team Approach

76. Post-Acute Rehabilitation After Stroke_ Getting It Right

77. Primary Care of Adult Patients After Stroke

78. Primary Endpoints in Acute Stroke Trials; mRS May Not Be Best

79. Pushing the Boundaries of Carotid Disease

80. Real-world outcomes associated with the use of the EmboTrap revascularization device for ischemic stroke in the US

81. Recent Innovations in Intracerebral Hemorrhage

82. Risk Factors and Prevention Oral Abstracts I

83. Risk Factors and Prevention Oral Abstracts II

84. Risk Factors and Prevention Oral Abstracts III

85. SPAN_Stroke Preclinical Assessment Network Design and Interim Analysis (a Joint AHA_ASA and NIH_NINDS Session)

86. State-of-the-Science Stroke Nursing Symposium_ Main Event

87. Strength in Numbers_ Late-Breaking Flow Diversion Clinical Evidence Explained

88. Stroke as a Social Disease_ Addressing Social Determinants of Health in Stroke Research and Clinical Care

89. Stroke Council Underrepresented Racial and Ethnic Travel Grant and Bernard J Tyson Career Development Award Recognition Rece…

90. Stroke Program Optimization

91. Taming the Beast_ Novel Treatment Strategies for Complex AVMs

92. Technology & Health in the Stroke Field

93. The Best of Both Worlds_ Combination Therapy for Ischemic Stroke

94. The impact of artificial intelligence in stroke. Today into the future

95. The role of CLEVIPREX (clevidipine) for BP reduction in stroke

96. Thursday Main Event

97. To Treat or Not to Treat – and If So, How_ Carotid Webs in Stroke

98. Tough Cases_controversies in Stroke Neurocritical Care

99. Translational Basic Science Oral Abstracts I

100. Translational Basic Science Oral Abstracts II

101. Translational Basic Science Oral Abstracts III

102. Treatment of ICAD_ Medical Management and Lifestyle

103. Under-Represented Samples in Stroke Trials

104. Vascular Contributions to Brain Health (a Stroke journal Session)